Umoja wa Ulaya -
Kidenmaki -
EMA (European Medicines Agency)
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakterielle midler til systemisk brug, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..
Denmaki -
Kidenmaki -
Lægemiddelstyrelsen (Danish Medicines Agency)
alluzience 200 enheder/ml injektionsvæske, opløsning
ipsen pharma - clostridium botulinum, type a toxin-haemagglutinin compleks - injektionsvæske, opløsning - 200 enheder/ml
Denmaki -
Kidenmaki -
Lægemiddelstyrelsen (Danish Medicines Agency)
tigecycline "eql pharma" 50 mg pulver til infusionsvæske, opløsning
eql pharma ab - tigecyclin - pulver til infusionsvæske, opløsning - 50 mg
Denmaki -
Kidenmaki -
Lægemiddelstyrelsen (Danish Medicines Agency)
tobramycin teva 300 mg/5 ml inhalationsv?ske til nebulisator, opl?sning
abacus medicine a/s - tobramycin - inhalationsvæske til nebulisator, opløsning - 300 mg/5 ml